China Baby Formula Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$3,250$7,500

The Chinese infant formula market is expected to rise due to many growth drivers including high female workforce share, growing middle class & dual-income families as well as increasing premium nutrition expenditure.

Clear

Description

China Baby Formula Market Overview

Product Overview

Infant formula is the closest replacement for an infant’s maternal breast milk. A mixture of dairy & other dietary ingredients makes baby formula. Infant formula is typically produced to feed infants under the age of 12 months to help them in promoting healthy growth and maintaining good health.

Baby formula is mixed by mixing powder and liquid for bottle-feeding or cup-feeding. The making of a formula for infants follows a certain protocol. The most basic steps involved in producing baby milk are liquid preparation from skim milk and mixture of ingredients, then the processing of the mixture is finished, followed by powder preparation and packaging of that powdered baby formula.

Market Highlights

China Baby Formula Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. The Chinese infant formula market is expected to rise due to many growth drivers including high female workforce share, growing middle class & dual-income families as well as increasing premium nutrition expenditure.

China is a major contributor to the global baby formula market and is driven by a growing population in China following the Chinese government’s abolition of the one-child policy in 2013, and a rise in middle-class income.

China Baby Formula Market: Segments

The infant milk segment is anticipated to register XX% of the market share during the forecasted period.
By product the market can be segmented into infant milk, follow up milk, specialty baby milk and growing up milk. Infant milk is expected to account for the largest market share due to an increase in physician’s preference to use infant milk as a replacement for breastfeeding, as it is a safe and nutritious alternative along with greater convenience.

Infant milk is also high in iron and helps avoid anemia. Specific baby milks are fortified with probiotics, which help avoid diarrhea, relieve colic and reduce the risk of allergies to food.

China Baby Formula: Market Dynamics

High female workforce and lifestyle changes to increase market growth

The Chinese infant formula market is expected to rise due to many growth drivers including high female workforce share, growing middle class & dual-income families as well as increasing premium nutrition expenditure.

Food safety concerns and low birth rate to hinder the market growth in China

Declining number of births of new born in China and foreign brands dominating the market of baby formula are factors likely to hamper the growth. Additionally, concerns related to food safety are also a major factor restricting the growth of the baby formula market in China.

China Baby Formula Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
Because of the existence of a large population under the age of 0 to 4 years, China is projected to be the largest revenue contributor to the global market. Rise in female labor force participation, increased disposable income, a busy lifestyle and high living standards in countries like China, is also expected to act as driving factors in the baby formula market.

The region segment can be further divided into five major types including North China, South China, East China and West China

China Baby Formula Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Baby Formula Market have been the improvement in healthcare facilities among key players and the increase in the standard of living of people coupled with the growth in preference for infant formula.

China Baby Formula Market: Key players

Nestle
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Danone
• Abbott Laboratories
• Feihe International Inc.
• Other prominent players
• Other prominent players
The China Baby Formula Market report also contains analysis on:

China Baby Formula Market segments: –

• By Type:

o Infant Milk
o Follow-on-Milk
o Specialty Baby Milk
o Growing-up Milk

• By Distribution channel:

o Hypermarkets
o Supermarkets
o Pharmacies
o Specialty Stores
o Hard Discounter Stores
o Others

• China Baby Formula Market dynamics
• China Baby Formula Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Fortified Dairy Products Market by Product Type (Fortified Milk, Formula Milk Powder, Cheese, Yoghurt and Others); By Age (Children, Elderly and Others); By Sales Channel (Convenience Stores, Departmental Stores, Hypermarkets and Supermarkets, Online Stores and Others); By Micronutrients (Vitamin, Calcium and Others) and Region – Analysis of Market Size, Share & Trends for 2017– 2019 and Forecasts to 2030

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. China Baby Formula Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Correlation & Regression Analysis
6.1. Correlation Matrix
6.2. Regression Matrix
7. Recent Development, Policies & Regulatory Landscape
8. Risk Analysis
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. China Baby Formula Market Analysis
9.1. Porters Five Forces
9.1.1. Threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. China Baby Formula Market
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. China Baby Formula Market: Market Segmentation

11.1.1. East China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. South China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. North China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. West China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. China Baby Formula Market: Market Segmentation
12.1. By type: Market Share (2020-2030F)
12.1.1. infant milk, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. follow up milk, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. specialty baby milk, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. growing up milk, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By distribution channel : Market Share (2020-2030F)
12.2.1. hypermarkets, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. supermarkets, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. pharmacies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. specialty stores, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. hard discounter stores, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile
13.1. Nestle
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Danone
13.3. Abbott Laboratories
13.4. Feihe International Inc.
13.5. Other prominent players

14. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.